Biote Corp (BTMD)
5.87
-0.08
(-1.34%)
USD |
NASDAQ |
May 15, 14:38
Biote Cash from Investing (Quarterly): -12.18M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.18M |
| December 31, 2023 | 19.00M |
| September 30, 2023 | -0.484M |
| June 30, 2023 | -20.84M |
| March 31, 2023 | -0.38M |
| Date | Value |
|---|---|
| December 31, 2022 | -0.311M |
| September 30, 2022 | -0.387M |
| June 30, 2022 | -0.658M |
| March 31, 2022 | -0.482M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-20.84M
Minimum
Jun 2023
19.00M
Maximum
Dec 2023
-1.859M
Average
-0.482M
Median
Mar 2022
Cash from Investing (Quarterly) Benchmarks
| Teladoc Health Inc | -35.51M |
| American Shared Hospital Services | -0.097M |
| Novo Integrated Sciences Inc | -- |
| Astrana Health Inc | -71.04M |
| Cryo-Cell International Inc | -0.341M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.372M |
| Cash from Financing (Quarterly) | -5.409M |
| Free Cash Flow | 17.88M |
| Free Cash Flow Per Share (Quarterly) | 0.1825 |
| Free Cash Flow to Equity (Quarterly) | 7.678M |
| Free Cash Flow to Firm (Quarterly) | 9.220M |
| Free Cash Flow Yield | 10.11% |